Perivascular Epithelioid Cell Neoplasms
"Perivascular Epithelioid Cell Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. These cells do not have a normal anatomic homolog. (From Fletcher CDM, et. al., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, 2002).
Descriptor ID |
D054973
|
MeSH Number(s) |
C04.557.450.692
|
Concept/Terms |
Clear-Cell Sugar Tumors- Clear-Cell Sugar Tumors
- Clear Cell Sugar Tumors
- Clear-Cell Sugar Tumor
- Sugar Tumor, Clear-Cell
- Sugar Tumors, Clear-Cell
- Tumor, Clear-Cell Sugar
- Tumors, Clear-Cell Sugar
Clear-Cell Myomelanocytic Tumors- Clear-Cell Myomelanocytic Tumors
- Clear Cell Myomelanocytic Tumors
- Clear-Cell Myomelanocytic Tumor
- Myomelanocytic Tumor, Clear-Cell
- Myomelanocytic Tumors, Clear-Cell
- Tumor, Clear-Cell Myomelanocytic
- Tumors, Clear-Cell Myomelanocytic
- CCMMT
|
Below are MeSH descriptors whose meaning is more general than "Perivascular Epithelioid Cell Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Perivascular Epithelioid Cell Neoplasms".
This graph shows the total number of publications written about "Perivascular Epithelioid Cell Neoplasms" by people in this website by year, and whether "Perivascular Epithelioid Cell Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Perivascular Epithelioid Cell Neoplasms" by people in Profiles.
-
Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. J Clin Oncol. 2024 May 01; 42(13):1472-1476.
-
Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Mod Pathol. 2024 Mar; 37(3):100426.
-
nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. J Clin Oncol. 2021 11 20; 39(33):3660-3670.
-
Sequencing PEComas: Viewing Unicorns through the Molecular Looking Glass. Oncology. 2021; 99(1):62-64.
-
Perivascular Epithelioid Cell Tumor of the Urinary Bladder: A Systematic Review. Int J Surg Pathol. 2020 Jun; 28(4):393-400.
-
Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. Hum Pathol. 2018 06; 76:149-155.
-
Rhabdoid Myomelanocytic Tumor (PEComa) of the Ovary: A Clinically Benign Case Followed for 7 Years. Int J Surg Pathol. 2016 Aug; 24(5):431-5.
-
Retroperitoneal PEComa related to the femoral nerve. J Neurosurg Sci. 2017 02; 61(1):109-112.
-
Resistance to mammalian target of rapamycin inhibitor therapy in perivascular epithelioid cell tumors. J Clin Oncol. 2010 Aug 20; 28(24):e415.